What is iScreen Vision?
iScreen Vision operates at the intersection of medical technology and pediatric healthcare, specializing in advanced digital vision screening solutions. The company's core offering is a sophisticated, user-friendly photoscreening device designed to facilitate rapid and accurate eye examinations for children as young as one year old. By enabling pediatricians, family practitioners, and school health professionals to detect vision abnormalities early, the firm plays a vital role in preventing permanent vision loss in young patients. With a track record of over 1.5 million screenings, iScreen Vision has established itself as a critical player in the diagnostic medical device sector, effectively bridging the gap between complex clinical diagnostics and accessible primary care.
How much funding has iScreen Vision raised?
iScreen Vision has raised a total of $11M across 5 funding rounds:
Private Equity
$3.3M
Private Equity
$3.5M
Series B
$4M
Debt
$150K
Debt
$160K
Private Equity (2010): $3.3M, investors not publicly disclosed
Private Equity (2013): $3.5M, investors not publicly disclosed
Series B (2013): $4M supported by MB Venture Partners
Debt (2020): $150K featuring PPP
Debt (2021): $160K backed by PPP
Key Investors in iScreen Vision
MB Venture Partners
MB Venture Partners is a Memphis-based venture capital firm that specializes in providing capital and strategic direction to life science companies, particularly in the medical device sector. The firm invests in start-ups at all stages of development, with a focus on product solutions for musculoskeletal diseases.
PPP
Public-Private Partnership
Undisclosed Investors
What's next for iScreen Vision?
With the recent influx of capital, iScreen Vision is well-positioned to accelerate its market expansion and enhance its diagnostic capabilities. The company's strategic roadmap likely involves scaling its distribution network to reach a broader demographic of pediatric clinics and educational institutions. Furthermore, the firm is expected to invest in R&D to refine its imaging technology, potentially integrating AI-driven analytics to further improve the accuracy and speed of its screening processes. As the company moves into its next phase of growth, the focus will remain on solidifying its market position as a leader in pediatric diagnostic solutions, while exploring new partnerships to integrate its technology into standard pediatric wellness protocols.
See full iScreen Vision company page
